Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04697355 · ClinicalTrials.gov registry record · NA
Effect of Naringenin and Beta Carotene on Energy Expenditure
A NA study of Safety Issues and Energy Expenditure, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- NA
- Development phase
- 1
- Enrollment target
- 1
- Study location
NCT04697355 is a NA study of Safety Issues and Energy Expenditure that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 1 participants, below the 120-participant average among 13 other Safety Issues trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04697355, a NA study of Safety Issues and Energy Expenditure, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed to test the effects of the combination of naringenin (from an extract of sweet oranges) and beta carotene on energy expenditure and glucose metabolism in a single human subject.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT naringenin and beta carotene
Study Locations (1)
Louisiana
- Pennington Biomedical Research Center - Baton Rouge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2021-04-19 |
| Est. Completion | 2021-08-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04697355
The ClinicalTrials.gov registry entry for NCT04697355 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 120-participant average among 13 other Safety Issues trials with a reported enrollment target (99% lower). The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Safety Issues appearing as the primary indexed condition, and to 1 intervention - of which naringenin and beta carotene is the first listed.
NCT04697355 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.
Frequently Asked Questions
What is clinical trial NCT04697355 about?
NCT04697355 is a clinical study titled "Effect of Naringenin and Beta Carotene on Energy Expenditure". This study is designed to test the effects of the combination of naringenin (from an extract of sweet oranges) and beta carotene on energy expenditure and glucose metabolism in a single human subject.
What is the current status of trial NCT04697355?
This trial is currently completed. It is a NA study. The enrollment target is 1 participants. The study started on 2021-04-19. Estimated completion is 2021-08-02.
What conditions does trial NCT04697355 study?
This clinical trial studies the following conditions: Safety Issues, Energy Expenditure, Glucose Metabolism.
What interventions are being tested in trial NCT04697355?
The interventions under investigation include: naringenin and beta carotene (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04697355?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04697355 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Safety Issues
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
BeSMART Secure Storage Counseling in the Inpatient Setting
RECRUITING · NA
-
Directed Use of REmote Patient Management System AMia to Achieve Prescribed Dry Weight
ACTIVE NOT RECRUITING · NA
-
Assessing the Effects of a Cannabidiol Derived From Hemp Supplement in Healthy Adults
COMPLETED · NA
-
Buck Institute Ketone Ester RCT
COMPLETED · NA
-
Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
Role of a CCK Receptor Antagonist Proglumide in Management of Chronic Pancreatitis
ACTIVE NOT RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.